Quarterly report pursuant to Section 13 or 15(d)

Stockholders' (Deficit) (Details 2)

v3.21.2
Stockholders' (Deficit) (Details 2) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Exercised (5,060)  
Warrant [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding, beginning 3,333  
Range of option/warrant price per share, outstanding, beginning $ 0.40  
Weighted Average Exercise Price Outstanding, beginning $ 0.40  
Weighted Average Contractual Life   3 years 6 months
Granted 2,871,250  
Weighted Average Exercise Price, Granted $ 6.97  
Weighted Average Contractual Life, Exercisable 5 years  
Exercised (455,390)  
Weighted Average Exercise Price, Granted $ 7.43  
Granted  
Weighted Average Exercise Price, Granted  
Outstanding, ending 2,419,193 3,333
Weighted Average Exercise Price Outstanding, ending $ 6.87 $ 0.40
Weighted Average Contractual Life, Exercisable 4 years 11 months 1 day  
Exercisable, ending 2,419,193  
Exercisable, ending $ 6.87  
Warrant [Member] | Minimum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Range of option/warrant price per share, Granted $ 7.43  
Range of option per share outstanding ending balance 7.43  
Range of option/warrant price per share, Exercisable ending $ 7.43  
Warrant [Member] | Maximum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Range of option/warrant price per share, Granted $ 6.67  
Range of option per share outstanding ending balance 0.40  
Range of option/warrant price per share, Exercisable ending $ 0.40